SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks
Scottsdale Scientific, Inc. (STDS)
An SI Board Since April 1999
Posts SubjectMarks Bans Symbol
105 0 0 STDS
Emcee:  ian Type:  Unmoderated
----------------------------------------
AHEAD OF THE STREET
aheadofthestreet.com
APRIL STOCK OF THE MONTH

A Business Financial Network Publication
bizfn.com
----------------------------------------

Scottsdale Scientific, Inc., through it's wholly owned subsidiary,
NutriCology, Inc./Allergy Research Group is an innovative leader in
research and the formulation of nutritional supplements. Scottsdale
Scientific, Inc. is a multi-national company positioned to profit in the
$92 billion annual Neutraceutical market.

NutriCology Inc./Allergy Research Group, Scottsdale's wholly owned
subsidiary was established in 1979. The company is the pioneering leader
in the nutritional health and life enhancement supplement market. This
established company is now under taking important initiatives to increase
revenues and earnings rapidly over the next few years.

----------------------------------------
Scottsdale Scientific, Inc.
7332 East Butherus Drive - Suite 101
Scottsdale, Arizona 85260
(888) 607-5399 or (602) 948-7444
e-Mail: stds@primenet.com
----------------------------------------

STOCK PRICE AND INFORMATION

Ticker Symbol: STDS
Recent Price: 1 7/8
52 Week Range: 1 5/16 - 5 7/16
Shares Outstanding: 15,030,000
Float: 5,000,000

Scottsdale Scientific, Inc. has several elements and factors that point to
very strong performance in the industry. The company is recognized
worldwide for the quality, purity, and efficacy of its nutritional
supplement line. This is exemplified by over 6,000 physicians and health
care practitioners who purchase the products and recommend them to their
patients. The company has the management, innovative products, and
industry reputation to capitalize on industry trends and growth.
Furthermore, Scottsdale Scientific, Inc. has expanded capacity and
established new distribution channels, including the Internet
nutricology.com that will support management's aggressive growth
plans and should produce an acceleration of revenues and earnings over the
next few years.

GROWTH INDUSTRY

* The nutritional supplement market is a rapidly growing sector of the
health and wellness market. It is growing at an annual rate of 20 - 30%.

* Neutraceuticals are a $92 Billion annual business
(Nutrition Business Journal, Dec. 1998)

* 113 million Baby Boomers alone, spend billions annually on their health.

* Amazing projected growth in Online Sales of Nutritional Supplements and
natural products in the nutrition industry.
$12 million in 1997
$40 million in 1998
$160 million projected for 1999
Over $500 million by 2001
(Nutrition Business Journal)

* The majority of the world's population use alternative medicine as their
primary source of medical care.

* Rapid increase in number of doctors recommending antioxidants and other
nutritional supplements.

* HMO's, such as Kaiser Permanente and Oxford Health, have initiated
programs of reimbursement for alternative healthcare in order to reduce
costs and improve patient quality of life.

STRONG MANAGEMENT TEAM

Scottsdale Scientific recently announced a management rotation to better
utilize strengths of the company's management team. Dr. Stephen Levine,
founder of Allergy Research Group and chairman of the board of Scottsdale
Scientific, has resigned his post as chief executive officer and chose to
become president of Allergy Research Group's research and development
company. This transition allows Levine to devote his full energies in
research and development and co-chairing Scottsdale Scientific's scientific
advisory board which exposes him to the very latest methodologies being
utilized.

Dr. Levine is recognized as one of the leading researchers and developers
of life enhancing nutritional products. Dr. Levine is also recognized as
an author of the internationally recognized book on antioxidants and free
radical pathology, "Antioxidant Adaptation, Its Role in Free Radical
Pathology" which is considered to be the leading resource on these subjects.

Marianne Sum, president and chief operating officer of Scottsdale
Scientific, has resigned her post of COO and assumed the Chief Executive
Officer position as well as retaining the presidency. As she stated,
"These management internal shifts are customary and to be expected in a
healthy, dynamic organization as it comes into its maturity in the public
arena. Dr. Levine and I have spent the last 14 months gaining confidence
and experience in our respective divisions."

We have spoken with Marianne Sum prior to developing this report and are
impressed with her vision and competence to take this company through the
next stages in the company's expansion. Her plans for domestic and
international growth are very solid and we have confidence in her ability
to position this 20 year-old company for accelerated growth into the next
millennium.

For more info on current/new management:
biz.yahoo.com

TAPPING NEW MARKETS AND DISTRIBUTION SOURCES

The company supplies products to more than 6,000 physicians and health care
practitioners in the United States. Physicians, health care practitioners
and consumers have the assurance that Scottsdale Scientific can meet their
needs with the over 250 quality nutritional products available. To assist
the consumer, the company offers a technical support team with extensive
background in the nutrition supplement field to answer any questions or
inquiries the customer may have (1-888-563-1506).

Also available is a 50 page catalog including (but not limited to):
Vitamin C Products, Multiple Vitamins/Minerals, Essential Fatty Acids,
Superfood Concentrates, Live Cell Therapy, Supplements for Immunological
and Autoimmune Disorders.

The company has divided sales into multiple market channels:

1. Allergy Research Group (Professional product line label) - Physicians,
Nutritionists, Chiropractors and health care professionals.

2. NutriCology, Inc. (Wholesale/Retail product line label) - wholesale
accounts such as Health Food Stores and direct catalog sales.

3. Private labeling to other health and wellness companies.

The company is now expanding beyond its core market to tap markets
internationally and penetrate the domestic market through the internet and
other retail distribution systems.

SCOTTSDALE SCIENTIFIC EXPANDING DISTRIBUTION WORLD-WIDE

The company has entered the multi-billion dollar European Nutraceutical
market (Nutraceutical's are nutritional products with potential therapeutic
value). The expansion into this market has been endorsed in the European
community by the St. George Cancer Clinic., a world renowned cancer
research center.

September 17, 1998- Scottsdale Scientific Announced distribution agreement
with United Kingdom based, Nutri-Link, Ltd.

nutricology.com

August 11, 1998- Scottsdale Scientific announced a multi-million dollar
international distribution agreement. The agreement gave Scottsdale
Scientific access to 7,000 distributors in 50 cities throughout South America.

nutricology.com

May 04, 1998
Scottsdale Scientific secured two international distributors

nutricology.com

These distribution agreements exemplify the company's commitment to expand
its product line world wide.

USE OF THE INTERNET

Ed Lau, Scottsdale Scientific's newly promoted General Manager states,
"This move into the Internet Commerce will greatly increase our presence in
the high-tech and retail marketing sector while increasing the sales and
profitability of our company. It is essential to make our products
available through the e-commerce network, as well as implement a strategic
marketing campaign to ensure the success through this alternative method of
purchasing our products."

nutricology.com

Jan. 12, 1999 Scottsdale Scientific, announced expanded retail
distribution over the Internet at nutricology.com

"Since the TOTAL IMMUNE™ product was introduced, in early December 1998,
the reception in the health care arena has been overwhelming," said
Marianne Sum, CEO of Stottsdale Scientific. The Internet provides the most
widespread distribution and marketing system to expand the company's
activities to the retail consumer. "Orders are coming in from Singapore,
Japan, Australia, New Zealand, United Kingdom, Germany, Brazil and the U.S.
Furthermore, the company has planned an aggressive Internet marketing
campaign to include every feasible aspect of the world-wide web." More
details regarding the internet marketing initiatives should be announced
shortly.

EXPANDED CAPACITY TO HANDLE INCREASED DEMAND FOR PRODUCTS

July 21, 1998- Scottsdale Scientific relocated to new state of the art
facility in Hayward, California. Scottsdale Scientific, Inc., through
their wholly owned subsidiary, NutriCology Inc., relocated to a new
25,000 sq. ft. modern facility in Hayward, California, replacing the aging
and antiquated 12,000 sq. ft. building in San Leandro, California.

This new facility enables Scottsdale Scientific to efficiently service the
exponential growth the company has been experiencing. Operational
improvements are projected to save the company millions of dollars over the
next 5 years.

INNOVATIVE PRODUCTS / INDUSTRY LEADERS

NutriCology was the first in the U.S. to introduce numerous specialty
products including melatonin, a neurohormone, germanium sesquioxide (a
trace mineral), AntiOx(tm), a broad spectrum antioxidant and Buffered
Vitamin C. Buffered Vitamin C was tested at the Haight Ashbury Clinic in
San Francisco as a nutritional supplement for its value (associated with
medical treatment) for opiate and stimulate abusers.

Specialty products already introduced include:

March 2, 1999 - Scottsdale Scientific introduced Total Heart and Total
Nerve the Latest Addition to the company's line of immunological targeted
supplements. Total Heart(TM) is a unique cardiovascular formula
specifically created for those people who are very active by their
profession, such as sports figures or for those people who want a higher
energy level and who need tissue damage repaired. The formulation includes
all the supplements needed for proper diet and early intervention in heart
conditions.

Total Nerve(TM) offers overall protection through nutritional supplements
that help improve the blood and oxygen supply and supports the immune
system as well as the brain. Total Nerve(TM) is a specific formula of
vitamins, minerals, herbs, hormones, amino acids (proteins) essential fatty
acids, and digest enzymes. These ingredients help maintain homeostasis in
the body and relate well to both the brain and cardiovascular system.

biz.yahoo.com

Scottsdale Scientific, in conjunction with the World Renowned Cancer Klinik
St. George of Bad Aibling, Germany introduced the first pre and post care
Nutritional Supplement - Total ImmuneTM. Total Immune<tm> is an all in one
dietary supplement powder containing over 60 nutrients, herbs and
immunostimulants. Dr. Douwes, founder of Klinik St. George, recognized the
necessity of pre-care detoxification and post-care nutrient support as part
of his therapies. Dr. Douwes' Kliniks, located in Germany and Las Vegas,
Nevada, are the world's largest cancer centers where alternative and
complementary cancer therapies are utilized along with extensive
detoxification protocols and chemotherapy.

The market for these products extends from new-borns to the elderly, a 300
million market in North America. The Total Nutrient Line alone will grow
the company's sales over 25% by year end 2000 and contribute to the
company's profitability.

RECOGNITION AND REPUTATION WITHIN THE INDUSTRY

May 27-30, 1998 -
Scottsdale Scientific, Inc. was invited to co-host the "International
Conference on Advanced Medicine in Immune Disorders and Cancer", in Bad
Aibling, Germany.

Scientists and physicians from around the world attended the conference to
learn of the latest breakthroughs and findings concerning immunity and
newly available clinical treatments. The conference was also sponsored by
the "German Society for Orthomolecular Medicine" and the world renowned
"Klinik St. George" of Bad Aibling, Germany. The Klinik St. George is the
foremost cancer treatment facility hospital in Germany and is well
respected internationally for its continuous research in the field of
innovative and natural cancer therapies.

nutricology.com

nutricology.com

March 8, 1999-- Scottsdale Scientific announced the establishment of the
company's elite Scientific Advisory Board

biz.yahoo.com

Dr. Levine, founder of Allergy Research Group and chairman of the board of
Scottsdale Scientific, also co-chairs Scottsdale Scientific's scientific
advisory board which exposes him to the very latest methodologies being
utilized. He is recognized as one of the leading researchers and developers
of life enhancing nutritional products. Dr. Levine is also wrote the
internationally recognized book on antioxidants and free radical pathology,
"Antioxidant Adaptation, Its Role in Free Radical Pathology" which is
considered to be the leading resource on these subjects.

SUMMARY:

Long term track record of sales growth and numerous new product line
introductions make Scottsdale Scientific, Inc. (OTC BB: STDS) a very
attractive play in the alternative medicine and nutritional supplement
industry. Because of demographics and changing health care consumption
patterns, the industry is poised to continue its rapid growth for the
foreseeable future. Scottsdale Scientific should benefit from this sector
growth and through the expanded distribution channels, including its use of
the Internet.

It should be noted, an independent firm, Gilbert & Chatterton initiated
coverage of Scottsdale Scientific last April with a Buy recommendation at
$3.50, significantly above current price levels. Since then, the company
has had a year of positive corporate developments and new product line
introductions.

----------------------------------------------------------------------------
Contact:

Investor Relations
Phone: (888) 607-5399

----------------------------------------------------------------------------

DISCLAIMER

© Copyright 1999, Business Financial Network, Inc. All rights reserved.

Business Financial Network, Inc. is not a Registered Investment Advisor or a
Broker / Dealer. This communication reflects opinions from Scottsdale
Scientific, Inc. (the Company). Readers are advised that this
electronic publication is issued solely for information purposes and is not
to be construed as an offer to sell or the solicitation of an offer to buy.

The opinions and analysis included herein are based on sources believed to
be reliable and in good faith but no representation or warranty, expressed
or implied, is made as to their accuracy, completeness or correctness. This
information is not intended to be used as the sole basis of any investment
decisions, nor should it be construed as advice designed to meet the
investment needs of any particular investor. The foregoing discussion
contains forward-looking statements which are based on current expectations
and differences can be expected.

The information contained herein has been provided by the Company to
Business Financial Network, Inc. for information purposes only; in
addition, the
information contained in this report is not intended to be a complete
discussion of information regarding some of the current and/or intended
business activities of the Company.

Readers are urged to consult with independent financial advisors with
respect to an investment in the shares mentioned herein. Investors should
review a complete information package on the Company, which should include,
but not be limited to, the Company's annual report, quarterly report, press
releases, as well as all regulatory filings. All information contained in
this report should be independently verified with the Company mentioned
herein. Any opinions expressed in this report are statements of judgment as
of the date of publication and are subject to change without further
notice, and may not necessarily be reprinted in future publications or
elsewhere. Neither Business Financial Network, Inc. nor its officers,
directors,
partners or employees / consultants accept liability whatsoever for any
direct or consequential loss arising from any use of this report or its
contents.

Business Financial Network, Inc. has been paid a fee of 28,000 free trading
shares of Scottsdale Scientific, Inc. (OTC BB: STDS) by Thor Equity Group for
consulting services including, but not limited to, research, project
analysis, and electronic dissemination of this report and other updates on
The Company. Employees and/or principals of Business Financial Network,
Inc. may
purchase shares on a voluntary basis in the open market and may buy or sell
shares in this company or others without prior notification depending on
market conditions and personal financial circumstances.

Prior to Business Financial Network, Inc. disseminating this information,
Thor Equity Group reviewed and approved the contents hereof.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE
INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS
SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.

We encourage the reader to review the investing information available with
the Securities and Exchange Commission ("SEC") at sec.gov and /
or the National Association of Securities Dealers ("NASD") at
nasdr.com. Readers can review all public filings by the Company
at the SEC's EDGAR page. The NASD has published information on how to
invest carefully at its web site.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
105 STDS filed a 10SB12G on 9/3/99 which includes a forecast for the 12 months of SCOOBEY-DO-2/12/2000
104 What happened to STDS? I see that the company is trying to catch up on their rSCOOBEY-DO-1/6/2000
103 Ian: There was a very good article in yesterday's Wall Street Journal concChip Roos-7/15/1999
102 Cool, now tell me Ian, what if any is the association between BizFn and pennystJim Bishop-6/29/1999
101 STDS selected as Stock of the Month by Penny Stock Picks: pennystockpicks.com ian-6/29/1999
100 For immediate release: 9:01am EST, June 22, 1999 Scottsdale Scientific Signs Larry Meneely-6/22/1999
99 Looks like it just bottomed out, anyone know where they are up to in their planscouser-6/22/1999
98 Ian, you and Alex, and BFN, have been pretty quiet lately, any particular reasoJim Bishop-5/28/1999
97 Monday May 17, 9:08 am Eastern Time Company Press Release Scottsdale ScientifJim Bishop-5/17/1999
96 BEST OF BFN NEWSLETTER bizfn.com May 6, 1999 A Business Financial Network PubJim Bishop-5/6/1999
95 Yuppers and a 300% increase in pharmacy market sales is also an mmmmmmm. <&Jim Bishop-5/6/1999
94 Volume up 200% today mmmmmm...... scouser-5/5/1999
93 Wednesday May 5, 9:06 am Eastern Time Company Press Release Scottsdale ScientJim Bishop-5/5/1999
92 Subject: BEST OF BFN NEWSLETTER - STDS Files to Become Fully Reporting; GBDI Jim Bishop-4/30/1999
91 mmm interesting... tim Tim Davies-4/30/1999
90 Jim, ya been busy. Thanks for your DD. The low for today was higher than yestescouser-4/30/1999
89 SCOTTSDALE SCIENTIFIC, INC. CONSOLIDATED STATEMENT Jim Bishop-4/30/1999
88 SCOTTSDALE SCIENTIFIC, INC. CONSOLIDATED BALANCE SHJim Bishop-4/30/1999
87 SCOTTSDALE SCIENTIFIC, INC. CONSOLIDATED BALANCE SHJim Bishop-4/30/1999
86 From the Clearstation board: From : goldlion Jim Bishop-4/30/1999
85 SUBMISSION: ACCESSION NUMBER: 0001023856-99-000017 TYPE: 10SB12Jim Bishop-4/29/1999
84 10ksb is at Edgar, but free Edgar won't let me read todays filings, and it&Jim Bishop-4/29/1999
83 New out today, now looking for the 10k. Thursday April 29, 9:22 am Eastern TimJim Bishop-4/29/1999
82 O/T Tim , checkout the education section at clearstation, you should print somescouser-4/28/1999
81 thanks.. for the clarification.. the charting is very interesting in its clearsTim Davies-4/28/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):